These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24686107)

  • 1. A community consultation survey to evaluate support for and success of the IMMEDIATE trial.
    Beshansky JR; Sheehan PR; Klima KJ; Hadar N; Vickery EM; Selker HP
    Clin Trials; 2014 Apr; 11(2):178-86. PubMed ID: 24686107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation of community consultation and public disclosure for a pediatric multi-centered "Exception from Informed Consent" trial.
    Holsti M; Zemek R; Baren J; Stanley RM; Mahajan P; Vance C; Brown KM; Gonzalez V; King D; Jacobsen K; Shreve K; van de Bruinhorst K; Jones AM; Chamberlain JM
    Clin Trials; 2015 Feb; 12(1):67-76. PubMed ID: 25369796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
    Ernst AA; Fish S
    Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public Deliberation as a Novel Method for an Exception From Informed Consent Community Consultation.
    Powers PE; Shore KK; Perez S; Ritley D; Kuppermann N; Holmes JF; Tzimenatos LS; Shawargga H; Nishijima DK
    Acad Emerg Med; 2019 Oct; 26(10):1158-1168. PubMed ID: 31271691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public Approval of Exception From Informed Consent in Emergency Clinical Trials: A Systematic Review of Community Consultation Surveys.
    Feldman WB; Hey SP; Franklin JM; Kesselheim AS
    JAMA Netw Open; 2019 Jul; 2(7):e197591. PubMed ID: 31339546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and surrogate attitudes via an interviewer-administered survey on exception from informed consent enrollment in the Prehospital Air Medical Plasma (PAMPer) trial.
    Campwala I; Guyette FX; Brown JB; Adams PW; Early BJ; Yazer MH; Neal MD; Zuckerbraun BS; Sperry JL
    BMC Emerg Med; 2020 Oct; 20(1):76. PubMed ID: 33004018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency research: using exception from informed consent, evaluation of community consultations.
    Govindarajan P; Dickert NW; Meeker M; De Souza N; Harney D; Hemphill CJ; Pentz R
    Acad Emerg Med; 2013 Jan; 20(1):98-103. PubMed ID: 23570483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services.
    Selker HP; Beshansky JR; Griffith JL; D'Agostino RB; Massaro JM; Udelson JE; Rashba EJ; Ruthazer R; Sheehan PR; Desvigne-Nickens P; Rosenberg YD; Atkins JM; Sayah AJ; Aufderheide TP; Rackley CE; Opie LH; Lambrew CT; Cobb LA; Macleod BA; Ingwall JS; Zalenski RJ; Apstein CS
    Am Heart J; 2012 Mar; 163(3):315-22. PubMed ID: 22424000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial.
    Selker HP; Harris WS; Rackley CE; Marsh JB; Ruthazer R; Beshansky JR; Rashba EJ; Peter I; Opie LH
    Am Heart J; 2016 Aug; 178():168-75. PubMed ID: 27502865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public support for and concerns regarding pediatric dose optimization for seizures in emergency medical services: An exception from informed consent (EFIC) trial.
    Ward CE; Adelgais KM; Holsti M; Jacobsen KK; Simon HK; Morris CR; Gonzalez VM; Lerner G; Ghaffari K; VanBuren JM; Lerner EB; Shah MI;
    Acad Emerg Med; 2024 Jul; 31(7):656-666. PubMed ID: 38450918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.
    Selker HP; Beshansky JR; Sheehan PR; Massaro JM; Griffith JL; D'Agostino RB; Ruthazer R; Atkins JM; Sayah AJ; Levy MK; Richards ME; Aufderheide TP; Braude DA; Pirrallo RG; Doyle DD; Frascone RJ; Kosiak DJ; Leaming JM; Van Gelder CM; Walter GP; Wayne MA; Woolard RH; Opie LH; Rackley CE; Apstein CS; Udelson JE
    JAMA; 2012 May; 307(18):1925-33. PubMed ID: 22452807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and implementation of community consultation for research conducted under exception from informed consent regulations for the PreVent and the PreVent 2 trials: Changes over time and during the COVID-19 pandemic.
    Gugel T; Adams K; Baranoski M; Yanez ND; Kampp M; Johnson T; Aydin A; Fajardo EC; Sharp E; Potnis A; Johnson C; Treggiari MM
    Clin Trials; 2024 Apr; ():17407745241243045. PubMed ID: 38676438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consulting communities when patients cannot consent: a multicenter study of community consultation for research in emergency settings.
    Dickert NW; Mah VA; Biros MH; Harney DM; Silbergleit R; Sugarman J; Veledar E; Weinfurt KP; Wright DW; Pentz RD
    Crit Care Med; 2014 Feb; 42(2):272-80. PubMed ID: 24145834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal-risk waiver of informed consent and exception from informed consent (Final Rule) studies at institutional review boards nationwide.
    Ernst AA; Weiss SJ; Nick TG; Iserson K; Biros MH
    Acad Emerg Med; 2005 Nov; 12(11):1134-7. PubMed ID: 16264084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conducting research using the emergency exception from informed consent: the Public Access Defibrillation (PAD) Trial experience.
    Mosesso VN; Brown LH; Greene HL; Schmidt TA; Aufderheide TP; Sayre MR; Stephens SW; Travers A; Craven RA; Weisfeldt ML;
    Resuscitation; 2004 Apr; 61(1):29-36. PubMed ID: 15081178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning from experience: a systematic review of community consultation acceptance data.
    Fehr AE; Pentz RD; Dickert NW
    Ann Emerg Med; 2015 Feb; 65(2):162-71.e3. PubMed ID: 25085547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exception from informed consent for pediatric resuscitation research: community consultation for a trial of brain cooling after in-hospital cardiac arrest.
    Morris MC; Nadkarni VM; Ward FR; Nelson RM
    Pediatrics; 2004 Sep; 114(3):776-81. PubMed ID: 15342853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 20-year Review: The Use of Exception From Informed Consent and Waiver of Informed Consent in Emergency Research.
    Klein L; Moore J; Biros M
    Acad Emerg Med; 2018 Oct; 25(10):1169-1177. PubMed ID: 29679443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in the application of exception from informed consent in a multicenter clinical trial.
    Carlson JN; Zive D; Griffiths D; Brown KN; Schmicker RH; Herren H; Sopko G; DiFiore S; Climer D; Herdeman C; Idris A; Nichol G; Wang HE
    Resuscitation; 2019 Feb; 135():1-5. PubMed ID: 30572072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.